<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        432-212-19
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2019
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        BENZAFLEX XR 30 mg Capsule
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CYCLOBENZAPRINE HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Capsule, hard
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        62.2
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="SPIMACO" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            SPIMACO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 488]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SPIMACO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            SPIMACO ADDWAEIH
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M03BX08 
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>BENZAFLEX XR is a prescription medicine used along with rest and physical therapy to help<br />treat muscle spasm due to acute, painful musculoskeletal problems.<br />BENZAFLEX XR should only be used for up to 2 or 3 weeks. It is not known if BENZAFLEX<br />XR is effective when used for longer periods. It is not known if BENZAFLEX XR is safe and<br />effective in children.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take BENZAFLEX XR if you:<br />&bull; Are allergic to cyclobenzaprine or any of the ingredients in BENZAFLEX XR. See the end<br />of this Patient Information leaflet for a complete list of ingredients in BENZAFLEX XR.<br />Talk to your healthcare provider or get medical help right away if you have symptoms of an<br />allergic reaction such as:<br />o difficulty breathing<br />o hives<br />o swelling of your face or tongue<br />o itching<br />&bull; Are taking certain antidepressants, known as monoamine oxidase (MAO) inhibitors or it has<br />been 14 days or less since you stopped taking a MAO inhibitor. Ask your healthcare provider<br />or pharmacist for a list of these medicines if you are not sure.<br />&bull; Have had a recent heart attack<br />&bull; Have heart rhythm problems (arrhythmias)<br />&bull; Have heart failure<br />&bull; Have an overactive thyroid (hyperthyroidism)</p><p>Talk to your healthcare provider before taking this medicine if you have any of the conditions<br />listed above.<br />Before you take BENZAFLEX XR, tell your healthcare provider if you:<br />&bull; Have a history of eye problems including glaucoma<br />&bull; Have heart problems or have had a heart attack<br />&bull; Have liver problems, cerebral palsy, brain or spinal cord disease, or stroke.<br />&bull; Have trouble emptying your bladder (urinary retention)<br />&bull; Are pregnant or plan to become pregnant. It is not known if BENZAFLEX XR will harm<br />your unborn baby.<br />&bull; Are breastfeeding or plan to breastfeed? It is not known if BENZAFLEX XR passes into<br />your breast milk. You and your healthcare provider should decide if you will take<br />BENZAFLEX or breastfeed.<br />BENZAFLEX XR may affect the way other medicines work, and other medicines may affect<br />how BENZAFLEX XR works. Tell your healthcare provider about all the medicines you take<br />including prescription and non-prescription medicines, vitamins, and herbal supplements.<br />Especially tell your healthcare provider if you take:<br />&bull; A medicine to treat depression, mood, anxiety, psychotic or thought disorders<br />&bull; A pain medicine called tramadol or meperidine<br />&bull; Barbiturates or other medicines that depress your central nervous system<br />&bull; A medicine that prevents nerve impulses (anticholinergic medicines)<br />&bull; A medicine to help quit smoking called bupropion<br />&bull; A blood pressure medicine called verapamil<br />Ask your doctor or pharmacist if you are not sure if you take any of the medicines listed above.<br />Know the medicines you take. Keep a list of your medicines and show it to your healthcare<br />provider or pharmacist when you get a new medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Take BENZAFLEX XR exactly as your healthcare provider tells you to take it.<br />&bull; Your healthcare provider will tell you how much BENZAFLEX XR to take and when to take<br />it.<br />&bull; Your healthcare provider may change your BENZAFLEX XR dose if needed.<br />&bull; Take BENZAFLEX XR by mouth with or without food. If stomach upset occurs, take with<br />food to reduce stomach irritation.<br />&bull; Swallow BENZAFLEX XR capsule whole. Do not break, crush, or chew before<br />swallowing.<br />&bull; BENZAFLEX XR should only be taken for short periods (up to two or three weeks).<br />&bull; BENZAFLEX XR works best if it is taken at the same time each day.<br />&bull; Do not suddenly stop taking BENZAFLEX XR without checking with your doctor.<br />For most patients, the recommended dose of BENZAFLEX XR is 15 mg once daily. Based on<br />individual patient response, the dose may be increased to 30 mg once daily.<br />If you took too much BENZAFLEX XR, call your doctor or go to the nearest hospital<br />emergency room right away.<br />You should not drink alcohol until you know how BENZAFLEX XR affects you. Taking<br />BENZAFLEX XR with alcohol or other medicines that depress your central nervous system<br />can slow your thinking and physical response times.</p><p>Do not drive, operate machinery, or do other dangerous activities until you know how<br />BENZAFLEX XR affects you.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, BENZAFLEX XR can cause side effects, although not everybody gets<br />them.<br />BENZAFLEX XR may cause serious side effects that may lead to heart attack or stroke. Call<br />your healthcare provider right away or go to the nearest hospital emergency room if you have:<br />&bull; Irregular or abnormal heartbeats (arrhythmias)<br />&bull; Fast heartbeat (tachycardia)<br />Serotonin syndrome is a serious medical condition that may happen when BENZAFLEX XR is<br />taken with certain other medicines. Call your healthcare provider right away or go to the<br />nearest hospital emergency emergency room if you become severely ill and have some or all of<br />these symptoms:<br />&bull; Agitation, hallucinations, coma or other changes in mental status<br />&bull; Coordination problems or muscle twitching (overactive reflexes)<br />&bull; Fast heartbeat, high or low blood pressure<br />&bull; Sweating or fever<br />&bull; Nausea, vomiting, or diarrhea<br />&bull; Muscle stiffness or tightness<br />The most common side effects of BENZAFLEX XR include:<br />&bull; Dry mouth<br />&bull; Dizziness<br />&bull; Fatigue<br />&bull; Constipation<br />&bull; Nausea<br />&bull; Upset stomach<br />&bull; Drowsiness<br />Tell your healthcare provider if you get any side effect that bothers you or that does not go<br />away.<br />If any of the side effects get serious, or if you notice any side effects not listed in this leaflet,<br />please tell your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; Keep out of the reach and sight of children.<br />&bull; Do not use BENZAFLEX XR after the expiry date, which is stated on the carton after<br />&ldquo;EXP&rdquo;.<br />&bull; Do not store above 30&deg;C.<br />&bull; Keep BENZAFLEX XR in a tightly closed container, and keep BENZAFLEX XR out<br />of light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>BENZAFLEX XR contains Cyclobenzaprine hydrochloride as active ingredients.<br />Each extended release capsule of BENZAFLEX XR 15 mg contains 15 mg of Cyclobenzaprine<br />hydrochloride.<br />Each extended release capsule of BENZAFLEX XR 30 mg contains 30 mg of Cyclobenzaprine<br />hydrochloride.</p><p>The other inactive materials are:<br />Hypromellose, Isopropyl alcohol, Methylene chloride, colloidal silicon dioxide, Ethyl<br />cellulose, &amp; sugar spheres.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Benzaflex XR 15mg Capsule: Size '4', hard gelatin capsule with light blue opaque cap and
light blue opaque body, containing white to off-white pellets. The capsule is printed with
“Benzaflex XR 15mg” on both parts.
Benzaflex XR 30mg Capsule: Size '3', hard gelatin capsule with dark green opaque cap and
dark green opaque body, containing white to off-white pellets. The capsule is printed with
“Benzaflex XR 30mg” on both parts.
Each pack contains 30 extended release capsule.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>SPIMACO<br />AlQassim pharmaceutical plant<br />Saudi Pharmaceutical Industries &amp;<br />Medical Appliance Corporation</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet is updated in May 2017.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>بينزافليكس إكس آر هو دواء يصرف بوصفة طبية يستخدم جنباً إلى جنب مع الراحة والعلاج الطبيعي للمساعدة في علاج<br />تشنج العضلات، ومشاكل العضلات والعظام المؤلمة و الحادة.<br />يجب أن يستخدم بينزافليكس إكس آر لمدة تصل إلى 2 أو 3 أسابيع فقط. فمن غير المعروف ما إذا كان بينزافليكس إكس آر<br />فعال عند استخدامه لفترات أطول. ومن غير المعروف ما إذا كان بينزافليكس إكس آر آمن وفعال في الأطفال.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>لا تتناول بينزافليكس إكس آر فى أى من الحالات الآتية:<br />&bull; إذا كانت لديك حساسية من سيكلوبينزابرين أو أي من مكونات بينزافليكس إكس آر. اطلع على نهاية هذه النشرة الموجهة<br />للمرضى للحصول على قائمة كاملة من مكونات بينزافليكس إكس آر.<br />تحدث إلى مقدم الرعاية الصحية الخاص بك أو احصل على المساعدة الطبية على الفور إذا كان لديك أعراض رد فعل<br />تحسسي مثل:<br />&minus; صعوبة في التنفس,<br />&minus; الشرى,<br />&minus; تورم فى الوجه أو اللسان,<br />&minus; حكة.</p><p>&bull; إذا كنت تتناول بعض مضادات الاكتئاب، والمعروفة باسم مثبطات أحادي أمين الأوكسيديز<br />اسأل طبيبك أو الصيدلي للحصول على قائمة هذه .MAO أقل منذ توقفت عن تناول مثبطات أحادي أمين الأوكسيديز<br />الأدوية إذا لم ك تن متأكدا.<br />&bull; إذا أصبت بنوبة قلبية مؤخر ا,ً<br />&bull; لديك مشاكل فى ضربات القلب (عدم انتظام ضربات القلب),<br />&bull; لديك فشل فى القلب<br />&bull; لديك فرط نشاط الغدة الدرقية (فرط نشاط الغدة الدرقية)<br />تحدث إلى مقدم الرعاية الصحية الخاص بك قبل تناول هذا الدواء إذا كان لديك أي من الحالات المذكورة أعلاه.<br />قبل أن تتناول بينزافليكس إكس آر أخبر طبيبك إذا كان:<br />&bull; لديك تاريخ من مشاكل في العين بما في ذلك الجلوكوما<br />&bull; لديك مشاكل في القلب أو أصبت بأزمات فى القلب<br />&bull; لديك مشاكل في الكبد, أو شلل دماغي, أو مرض فى الحبل الشوكي أو الدماغ, أو السكتة الدماغية.<br />&bull; لديك مشكلة في إفراغ المثانة الخاصة بك (احتباس البول)<br />&bull; إذا كنتِ حاملا أو تخططين لتصبحى حاملا. فمن غير المعروف ما إذا بينزافليكس إكس آر سوف يضر طفلك الذي لم<br />يولد بعد.<br />&bull; إذا كنتِ تقومين بالرضاعة الطبيعية أو تعتزمي القيام بالرضاعة الطبيعية. فمن غير المعروف ما إذا كان بينزا لي فكس<br />إكس آر يمر إلى حليب الثدي الخاص بك. يجب عليك ومقدم الرعاية الصحية الخاص بك أن تقررا ما إذا كنتِ سوف<br />تتناولى بينزافليكس إكس آر أو تقومى بالرضاعة الطبيعية.<br />قد يؤثر بينزافليكس إكس آر على طريقة عمل الأدوية الأخرى، وبعض الأدوية قد تؤثر على طريقة عمل بينزا لي فكس إكس<br />آر. اخبر مقدم الرعاية الصحية عن جميع الأدوية التي تتناولها بما في ذلك الأدوية الوصفية والغير وصفية والفيتامينات<br />والمكملات العشبية.<br />أخبر مقدم الرعاية الصحية الخاص بك خصوصا إذا كنت تتناول:<br />&bull; دواء لعلاج الاكتئاب، والمزاج، والقلق، والاضطرابات الذهانية أو التفكير<br />&bull; أدوية للآلام تسمى ترامادول أو ميبيريدين<br />&bull; الباربيتورات أو غيرها من الأدوية التي تثبط الجهاز العصبي المركزي<br />&bull; دواء يمنع النبضات العصبية (أدوية مضادات الكولين)<br />&bull; دواء للمساعدة على الإقلاع عن التدخين يسمى بوبروبيون<br />&bull; دواء لعلاج ضغط الدم يسمى فيراباميل<br />إسأل طبيبك أو الصيدلي إذا لم تكن متأكدا إذا كنت تتناول أي من الأدوية المذكورة أعلاه. اعرف الأدوية التي تتناولها. احتفظ<br />بقائمة الأدوية الخاصة بك وأظهرها لمقدم الرعاية الصحية أو الصيدلي عند الحصول على دواء جديد.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>تناول بينزافليكس إكس آر تماما كما أخبرك مقدم الرعاية الصحية الخاصة بك أن تتناوله.<br />&bull; سوف يخبرك مقدم الرعاية الصحية الخاصة بك كم تتناول من بينزافليكس إكس آر ومتى تتناوله.<br />&bull; قد يغير مقدم الرعاية الصحية الخاص بك جرعة بينزافليكس إكس آر الخاصة بك إذا لزم الأمر.</p><p>&bull; تناول بينزافليكس إكس آر عن طريق الفم مع أو بدون الطعام. إذا حدث اضطراب في المعدة, قم بتناول بينزافليكس إكس<br />آر مع الطعام للحد من تهيج المعدة.<br />&bull; قم بابتلاع الكبسولة بالكامل. لا تقم بكسر أو سحق أو مضغ الكبسولات قبل ابتلاعها.<br />&bull; ينبغي أن تتناول بينزافليكس إكس آر لفترات قصيرة (تصل إلى أسبوعين أو ثلاثة أسابيع).<br />&bull; بينزافليكس إكس آر يعمل بشكل أفضل عند تناول الجرعة فى نفس الوقت من كل يوم.<br />&bull; لا تتوقف فجأة عن تناول بينزافليكس إكس آر بدون الرجوع إلى طبيبك المعالج.<br />بالنسبة لمعظم المرضى، الجرعة الموصى بها من بينزافليكس إكس آر هي 15 ملجم مرة واحدة في اليوم. و يمكن زيادة<br />الجرعة بناء على استجابة المريض إلى 30 ملجم مرة واحدة في اليوم.<br />إذا تناولت الكثير من بينزافليكس إكس آر, اتصل بالطبيب أو اذهب إلى أقرب قسم الطوارئ فى المستشفى على الفور.<br />يجب أن لا تشرب الكحول حتى تعرف كيف يؤثر بينزافليكس إكس آر عليك. تناول بينزافليكس إكس آر مع الكحول أو<br />الأدوية الأخرى التي تخفض الجهاز العصبي المركزي يمكن أن يبطئ التفكير وأوقات الاستجابة الجسدية.<br />لا تقود السيارة، أو تشغل آلات، او تقوم بأنشطة أخرى خطيرة حتى تعرف كيف يؤثر بينزافليكس إكس آر عليك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية، يمكن أن يتسبب بينزافليكس إكس آر في آثار جانبية، على الرغم من أن الجميع لا يصاب بها.<br />قد يتسبب بينزافليكس إكس آر في أعراض جانبية خطيرة قد تؤدي إلى أزمة قلبية أو سكتة دماغية. اتصل بمقدم الرعاية<br />الصحية الخاص بك على ال و فر أو اذهب إلى أقرب قسم الطوارئ فى المستشفى إذا كان لديك:<br />&bull; عدم انتظام ضربات القلب (عدم انتظام ضربات القلب)<br />&bull; ضربات القلب السريعة (تسارع القلب)<br />متلازمة السيروتونين هو حالة طبية خطيرة قد تحدث عندما تتناول بينزافليكس إكس آر مع بعض الأدوية الأخرى. اتصل<br />بمقدم الرعاية الصحية الخاص بك على الفور أو اذهب إلى أقرب قسم الطوارئ في المستشفى إذا كنت مريضا بشدة و لديك<br />بعض أو كل هذه الأعراض:<br />&bull; التهيج، الهلوسة، غيبوبة أو غيرها من التغييرات في الحالة العقلية<br />&bull; مشاكل التنسيق أو ارتعاش العضلات (فرط نشاط ردود الفعل)<br />&bull; ضربات ا ق للب السريعة، وارتفاع أو انخفاض ضغط الدم<br />&bull; التعرق أو حمى<br />&bull; الغثيان والقيء، أو الإسهال<br />&bull; تصلب العضلات<br />الأعراض الجانبية الأكثر شيوعا مع بينزافليكس إكس آر ما يلي:<br />&bull; جفاف الفم<br />&bull; دوخة<br />&bull; التعب<br />&bull; الإمساك<br />&bull; الغثيان<br />&bull; اضطراب في المعدة<br />&bull; الخمول<br />أخبر طبيبك إذا حدث لك أي اعراض جانبية و أزعجتك أو لا تنتهى.<br />إذا لاحظت أن أيا من هذه الأعراض الجانبية أصبح جسيما، أو إذا لاحظت ظهور أى أعراض جانبية لم ترد فى هذه النشرة<br />فإنه يرجى أن تخبر طبيبك المعالج أو الصيدلى الذى تتعامل معه بشأنها.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&bull; يحفظ الدواء بعيدا عن متناول ونظر الأطفال.<br />.&quot;EXP&quot; &bull; لا تستعمل أقراص بينزافليكس بعد انتهاء تاريخ الصلاحية المدون على العبوة بعد<br />&bull; لا يحفظ في درجة حرارة أعلى من 30 درجة مئوية.<br />&bull; احفظ بينزافليكس إكس آر في حاوية مغلقة بإحكام، واحفظ بينزافليكس إكس آر بعيدا عن الضوء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحتوي بينزافليكس إكس آر على سيكلوبينزابرين هيدروكلورايد كمادة فعالة.<br />تحتوي كل كبسولة جيلاتينية صلبة ممتدة المفعول من بينزافليكس إكس آر 15 ملجم على 15 ملجم من سيكلوبينزابرين<br />هيدروكلورايد.<br />تحتوي كل كبسولة جيلاتينية صلبة ممتدة المفعول من بينزافليكس إكس آر 30 ملجم على 30 ملجم من سيكلوبينزابرين<br />هيدروكلورايد.<br />المواد الأخرى الغير فعالة هي:<br />هيبروميللوز, كحول أيزوبروبيل, ميثيلين كلورايد, ثانى أكسيد سيليكون غروى, إيثيل سيليولوز وسكر.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:right">بينزافليكس إكس آر 15 ملجم كبسولات: كبسولة جيلاتينية صلبة ممتدة المفعول حجم 4, ذات غطاء أزرق فاتح ولونها<br />أزرق فاتح, تحتوي على كريات لونها من أبيض إلى أبيض فاتح. مطبوع على الكبسولة &quot;بنزافلكس إكس آر 15 ملجم&quot; على<br />كلا الجانبين.<br />بينزافليكس إكس آر 30 ملجم كبسولات: كبسولة جيلاتينية صلبة ممتدة المفعول حجم 3, ذات غطاء أخضر قاتم ولونها<br />أخضر قاتم, تحتوي على كريات لونها من أبيض إلى أبيض فاتح. مطبوع على الكبسولة &quot;بنزافلكس إكس آر 30 ملجم&quot; على<br />كلا الجانبين.<br />تحتوى كل عبوة على 30 كبسولة جيلاتينية صلبة ممتدة المفعول.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>الدوائية<br />مصنع الأدوية بالقصيم<br />الشركة السعودية للصناعات الدوائية والمستلزمات الطبية.<br />المملكة العربية السعودية</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت الموافقة على هذه النشرة بتاريخ مايو 2017
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                BENZAFLEX XR 15 mg Extended Release Capsules
BENZAFLEX XR 30 mg Extended Release Capsules

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                BENZAFLEX XR 15 mg Extended Release Capsules: each Extended Release capsule
contains 15 mg cyclobenzaprine hydrochloride.
BENZAFLEX XR 30 mg Extended Release Capsules: each Extended Release capsule
contains 30 mg cyclobenzaprine hydrochloride
The other ingredients:
BENZAFLEX XR 15 mg Extended Release Capsules: each Extended Release capsule
contains 49.8 mg sugar spheres.
BENZAFLEX XR 30 mg Extended Release Capsules: each Extended Release capsule
contains 99.6 mg sugar spheres.
For a full list of excipients see section 6.1

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hard Gelatin Capsules.

BENZAFLEX XR 15mg Extended Release Capsule:
Size '4', hard gelatin capsule with light blue opaque cap and
light blue opaque body, containing white to off-white pellets.
The capsule is printed with “BENZAFLEX XR 15mg” on both
parts.

BENZAFLEX XR 30mg Extended Release Capsule:
Size '3', hard gelatin capsule with dark green opaque cap and
dark green opaque body, containing white to off-white pellets.
The capsule is printed with “BENZAFLEX XR 30mg” on both
parts.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>BENZAFLEX XR&reg; (cyclobenzaprine hydrochloride) is indicated as an adjunct to rest and<br />physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal</p><p>conditions. Improvement is manifested by relief of muscle spasm and its associated signs and<br />symptoms, namely, pain, tenderness, and limitation of motion.<br />Limitations of Use:<br />&middot; BENZAFLEX XR should be used only for short periods (up to two or three weeks) because<br />adequate evidence of effectiveness for more prolonged use is not available and because muscle<br />spasm associated with acute, painful musculoskeletal conditions is generally of short duration<br />and specific therapy for longer periods is seldom warranted.<br />&middot; BENZAFLEX XR has not been found effective in the treatment of spasticity associated with<br />cerebral or spinal cord disease or in children with cerebral palsy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>For oral administration.</u><br />For most patients, the recommended dose of BENZAFLEX XR is 15 mg once daily. Based on<br />individual patient response, the dose may be increased to 30 mg once daily. Use of<br />BENZAFLEX XR<br />for periods longer than two or three weeks is not recommended.<br />&middot; It is recommended that doses be taken at approximately the same time each day.<br />&middot; Use of BENZAFLEX XR for periods longer than two or three weeks is not recommended.</p><p><strong>Use in hepatic impairment</strong><br />As a result of two-fold higher cyclobenzaprine plasma levels in subjects with mild hepatic<br />impairment, as compared to healthy subjects, following administration of immediate-release<br />cyclobenzaprine and because there is limited dosing flexibility with BENZAFLEX XR, use of<br />BENZAFLEX XR is not recommended in patients with mild, moderate or severe hepatic<br />impairment.</p><p><strong>Pediatric Use</strong><br />Safety and effectiveness of BENZAFLEX XR has not been studied in pediatric patients.</p><p><strong>Use in the Elderly</strong><br />As a result of a 40% increase in cyclobenzaprine plasma levels and a 56% increase in plasma<br />half-life following administration of BENZAFLEX XR in elderly subjects as compared to<br />young adults, use of BENZAFLEX XR is not recommended in the elderly.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to any component of this product. These adverse reactions may manifest as an
anaphylactic reaction, urticaria, facial and/or tongue swelling or pruritus. Discontinue
BENZAFLEX XR if a hypersensitivity reaction is suspected.
• Concomitant use of monoamine oxidase (MAO) inhibitors or within 14 days after their
discontinuation. Hyperpyretic crisis seizures and deaths have occurred in patients receiving
inhibitor drugs.
• During the acute recovery phase of myocardial infarction, and in patients with arrhythmias,
heart block or conduction disturbances, or congestive heart failure.
• Hyperthyroidism.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Serotonin Syndrome</strong><br />The development of a potentially life-threatening serotonin syndrome has been reported with<br />cyclobenzaprine when used in combination with other drugs, such as selective serotonin<br />reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors, (SNRIs), tricyclic<br />antidepressants (TCAs), tramadol, bupropion, meperidine, verapamil, or MAO inhibitors. The<br />concomitant use of BENZAFLEX XR with MAO inhibitors is contraindicated [see 4.3<br />Contraindications]. Serotonin syndrome symptoms may include mental status changes (e.g.,<br />confusion, agitation, hallucinations), autonomic instability (e.g., diaphoresis, tachycardia, labile<br />blood pressure, hyperthermia), neuromuscular abnormalities (e.g., tremor, ataxia,<br />hyperreflexia, clonus, muscle rigidity), and/or gastrointestinal symptoms (e.g. nausea,<br />vomiting, diarrhea). Treatment with BENZAFLEX XR and any concomitant serotonergic<br />agents should be discontinued immediately if the above reactions occur and symptomatic<br />treatment should be initiated. If concomitant treatment with BENZAFLEX XR and other<br />serotonergic drugs is clinically warranted, careful observation is advised, particularly during<br />treatment initiation or dose increases.</p><p><strong>Tricyclic Antidepressant-like Effects</strong><br />Cyclobenzaprine is structurally related to the tricyclic antidepressants, e.g., amitriptyline and<br />imipramine. Tricyclic antidepressants have been reported to produce arrhythmias, sinus<br />tachycardia, prolongation of the conduction time leading to myocardial infarction and stroke.<br />BENZAFLEX XR may enhance the effects of alcohol, barbiturates, and other CNS<br />depressants.<br />Some of the more serious central nervous system (CNS) reactions noted with the tricyclic<br />antidepressants have occurred in short-term studies of cyclobenzaprine for indications other<br />than muscle spasm associated with acute musculoskeletal conditions, and usually at doses<br />somewhat greater than those recommended for skeletal muscle spasm. If clinically significant<br />CNS symptoms develop, consider discontinuation of BENZAFLEX XR.</p><p><strong>Use in the Elderly</strong><br />As a result of a 40% increase in cyclobenzaprine plasma levels and a 56% increase in plasma<br />half-life following administration of BENZAFLEX XR in elderly subjects as compared to<br />young adults, use of BENZAFLEX XR is not recommended in the elderly.</p><p><strong>Use in Patients with Hepatic Impairment</strong><br />As a result of two-fold higher cyclobenzaprine plasma levels in subjects with mild hepatic<br />impairment, as compared to healthy subjects, following administration of immediate-release<br />cyclobenzaprine and because there is limited dosing flexibility with BENZAFLEX XR, use of</p><p>BENZAFLEX XR is not recommended in patients with mild, moderate or severe hepatic<br />impairment.</p><p><strong>Atropine-like Action</strong><br />Because of its atropine-like action, BENZAFLEX XR should be used with caution in patients<br />with a history of urinary retention, angle-closure glaucoma, increased intraocular pressure, and<br />in patients taking anticholinergic medication.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Based on its structural similarity to tricyclic antidepressants, BENZAFLEX XR may have lifethreatening<br />interactions with MAO inhibitors [see 4.3 Contraindications], may enhance the<br />effects of alcohol, barbiturates, and other CNS depressants, may enhance the seizure risk in<br />patients taking tramadol, or may block the antihypertensive action of guanethidine and<br />similarly acting compounds.<br />Postmarketing cases of serotonin syndrome have been reported during combined use of<br />cyclobenzaprine and other drugs, such as SSRIs, SNRIs, TCAs, tramadol, bupropion,<br />meperidine, verapamil, or MAO inhibitors. [See 4.4 Special warnings and precautions for use]</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy</strong><br />Pregnancy Category B:<br />There are no adequate and well-controlled studies of BENZAFLEX XR in pregnant women.<br />Because animal reproduction studies are not always predictive of human response,<br />BENZAFLEX XR should be used during pregnancy only if clearly needed.<br />No treatment-related effects on embryofetal development were observed in mice and rabbits at<br />approximately 3 and 15 times the maximum recommended human dose (MRHD), respectively<br />(on a mg/m2 basis at maternal doses of 20 mg/kg/day in both mice and rabbits).</p><p><strong>Nonteratogenic Effects</strong><br />Cyclobenzaprine has been shown to adversely affect pup postnatal development when dams<br />were treated with the drug during pregnancy and lactation periods in rats. This study found that<br />cyclobenzaprine decreased pup body weight and survival at approximately &ge;3 times the<br />MRHD (on a mg/m2 basis at maternal doses of 10 and 20 mg/kg/day in rats).</p><p><strong>Nursing Mothers</strong><br />It is not known whether this drug is excreted in human milk. Because cyclobenzaprine is<br />closely related to the tricyclic antidepressants, some of which are known to be excreted in<br />human milk, caution should be exercised when BENZAFLEX XR is administered to a nursing<br />woman.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>You should not drink alcohol until you know how BENZAFLEX XR affects you. Taking<br />BENZAFLEX XR with alcohol or other medicines that depress your central nervous system<br />can slow your thinking and physical response times.<br />Do not drive, operate machinery, or do other dangerous activities until you know how<br />BENZAFLEX XR affects you.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>General</strong><br />The most frequently occurring adverse reactions have included dry mouth, dizziness, fatigue,<br />constipation, nausea, dyspepsia, and somnolence.</p><p><strong>Nervous system</strong><br />Very common (10% or more): Drowsiness (up to 38%)<br />Common (1% to 10%): Dizziness, somnolence<br />Postmarketing reports: Headache, serotonin syndrome, seizures, ataxia, tremors, hypertonia,<br />convulsions, abnormal sensations, paresthesia, and ageusia<br />Elderly patients may be particularly susceptible to the sedation and confusion which may<br />accompany cyclobenzaprine therapy.</p><p><strong>Psychiatric</strong><br />Common (1% to 10%): Irritability, mental acuity decreased, nervousness.<br />Postmarketing reports: Nervousness, confusion, disorientation, insomnia, depressed mood,<br />anxiety, agitation, psychosis, abnormal thinking and dreaming, hallucinations, excitement</p><p><strong>Hypersensitivity</strong><br />Postmarketing reports: Anaphylaxis, angioedema, pruritus, facial edema, urticaria, rash.</p><p><strong>Gastrointestinal</strong><br />Very common (10% or more): Dry mouth (up to 32%)<br />Common (1% to 10%): Constipation, nausea, dyspepsia, abdominal pain, acid regurgitation,<br />diarrhea<br />Postmarketing reports: Unpleasant taste, vomiting, anorexia, gastritis, thirst, flatulence, tongue<br />edema.</p><p><strong>Hepatic</strong><br />Postmarketing reports: Abnormal liver function, hepatitis, jaundice, cholestasis.</p><p><strong>Cardiovascular</strong><br />Postmarketing reports: Syncope, tachycardia, arrhythmia, vasodilation, palpitation,<br />hypotension.</p><p><strong>Other</strong><br />Common (1% to 10%): Fatigue<br />Postmarketing reports: Asthenia, malaise, vertigo.</p><p><strong>Dermatologic</strong><br />Postmarketing reports: Sweating.</p><p><strong>Genitourinary</strong><br />Postmarketing reports: Urinary frequency and/or retention.</p><p><strong>Musculoskeletal</strong><br />Postmarketing reports: Local weakness, dysarthria, muscle twitching.</p><p><strong>Ocular</strong><br />Postmarketing reports: Blurred vision, diplopia, tinnitus.</p><p><strong>Respiratory</strong><br />Common (1% to 10%): Upper respiratory infection, pharyngitis.</p><table border="0" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>To report any side effect(s):<em> </em></strong></p><p>- The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>o Fax: +966-11-205-7662</p><p>o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>o Toll free phone: 8002490000</p><p>o E-mail: npc.drug@sfda.gov.sa</p><p>o Website: www.sfda.gov.sa/npc</p></td></tr></tbody></table></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Although rare, deaths may occur from overdosage with BENZAFLEX XR. Multiple drug<br />ingestion (including alcohol) is common in deliberate cyclobenzaprine overdose.<br />As management of overdose is complex and changing, it is recommended that the physician<br />contact a poison control center for current information on treatment. Signs and symptoms of<br />toxicity may develop rapidly after cyclobenzaprine overdose; therefore, hospital monitoring is<br />required as soon as possible.</p><p><strong>Manifestations</strong><br />The most common effects associated with cyclobenzaprine overdose are drowsiness and<br />tachycardia. Less frequent manifestations include tremor, agitation, coma, ataxia, hypertension,<br />slurred speech, confusion, dizziness, nausea, vomiting, and hallucinations. Rare but potentially<br />critical manifestations of overdose are cardiac arrest, chest pain, cardiac dysrhythmias, severe<br />hypotension, seizures, and neuroleptic malignant syndrome. Changes in the electrocardiogram,<br />particularly in QRS axis or width, are clinically significant indicators of cyclobenzaprine<br />toxicity. Other potential effects of overdosage include any of the symptoms listed under<br />Adverse Reactions.</p><p><strong>Management</strong><br /><u>General</u><br />As management of overdose is complex and changing, it is recommended that the physician<br />contact a poison control center for current information on treatment.<br />In order to protect against the rare but potentially critical manifestations described above,<br />obtain an ECG and immediately initiate cardiac monitoring. Protect the patient&rsquo;s airway,<br />establish an intravenous line, and initiate gastric decontamination. Observation with cardiac<br />monitoring and observation for signs of CNS or respiratory depression, hypotension, cardiac<br />dysrhythmias and/or conduction blocks, and seizures is necessary. If signs of toxicity occur at<br />any time during this period, extended monitoring is required. Monitoring of plasma drug levels<br />should not guide management of the patient. Dialysis is probably of no value because of low<br />plasma concentrations of the drug.</p><p><u>Gastrointestinal Decontamination</u><br />All patients suspected of an overdose with BENZAFLEX XR should receive gastrointestinal<br />decontamination. This should include large volume gastric lavage followed by activated<br />charcoal. If consciousness is impaired, the airway should be secured prior to lavage and emesis<br />is contraindicated.</p><p><u>Cardiovascular</u><br />A maximal limb-lead QRS duration of 0.10 seconds may be the best indication of the severity<br />of the overdose. Serum alkalinization, to a pH of 7.45 to 7.55, using intravenous sodium<br />bicarbonate and hyperventilation (as needed), should be instituted for patients with<br />dysrhythmias and/or QRS widening. A pH &gt;7.60 or a pCO2 &lt;20 mmHg is undesirable.<br />Dysrhythmias unresponsive to sodium bicarbonate therapy/hyperventilation may respond to<br />lidocaine, bretylium, or phenytoin. Type 1A and 1C antiarrhythmics are generally<br />contraindicated (e.g., quinidine, disopyramide, and procainamide).</p><p><u>CNS</u><br />In patients with CNS depression, early intubation is advised because of the potential for abrupt<br />deterioration. Seizures should be controlled with benzodiazepines or, if these are ineffective,<br />other anticonvulsants (e.g., phenobarbital, phenytoin). Physostigmine is not recommended<br />except to treat life-threatening symptoms that have been unresponsive to other therapies, and<br />then only in close consultation with a poison control center.</p><p><u>Psychiatric Follow-Up</u><br />Since overdosage is often deliberate, patients may attempt suicide by other means during the<br />recovery phase. Psychiatric referral may be appropriate.</p><p><u>Pediatric Management</u><br />The principles of management of child and adult overdosage are similar. It is strongly<br />recommended that the physician contact the local poison control center for specific pediatric<br />treatment.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ATC Code: M03BX08<br />Cyclobenzaprine HCl relieves skeletal muscle spasm of local origin without interfering with<br />muscle function. It is ineffective in muscle spasm due to central nervous system disease.</p><p>Cyclobenzaprine reduced or abolished skeletal muscle hyperactivity in several animal models.<br />Animal studies indicate that cyclobenzaprine does not act at the neuromuscular junction or<br />directly on skeletal muscle. Such studies show that cyclobenzaprine acts primarily within the<br />central nervous system at brain stem as opposed to spinal cord levels, although its action on the<br />latter may contribute to its overall skeletal muscle relaxant activity. Evidence suggests that the<br />net effect of cyclobenzaprine is a reduction of tonic somatic motor activity, influencing both<br />gamma (&gamma;) and alpha (&alpha;) motor systems.<br />Pharmacological studies in animals showed a similarity between the effects of cyclobenzaprine<br />and the structurally related tricyclic antidepressants, including reserpine antagonism,<br />norepinephrine potentiation, potent peripheral and central anticholinergic effects, and sedation.<br />Cyclobenzaprine caused slight to moderate increase in heart rate in animals.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Estimates of mean oral bioavailability of cyclobenzaprine range from 33% to 55%.<br />Cyclobenzaprine exhibits linear pharmacokinetics over the dose range 2.5 mg to 10 mg, and is<br />subject to enterohepatic circulation. It is highly bound to plasma proteins. Drug accumulates<br />when dosed three times a day, reaching steady-state within 3-4 days at plasma concentrations<br />about four-fold higher than after a single dose. At steady state in healthy subjects receiving 10<br />mg t.i.d. (n=18), peak plasma concentration was 25.9 ng/mL (range, 12.8-46.1 ng/mL), and<br />area under the concentration-time (AUC) curve over an 8-hour dosing interval was 177<br />ng.hr/mL (range, 80-319 ng.hr/mL).</p><p>Cyclobenzaprine is extensively metabolized, and is excreted primarily as glucuronides via the<br />kidney. Cytochromes P-450 3A4, 1A2, and, to a lesser extent, 2D6, mediate N-demethylation,<br />one of the oxidative pathways for cyclobenzaprine. Cyclobenzaprine is eliminated quite<br />slowly, with an effective half-life of 18 hours (range 8-37 hours; n=18); plasma clearance is 0.7<br />L/min.</p><p>The plasma concentration of cyclobenzaprine is generally higher in the elderly and in patients<br />with hepatic impairment.</p><p><strong>Elderly</strong><br />In a pharmacokinetic study in elderly individuals (&ge;65yrs old), mean (n=10) steady-state<br />cyclobenzaprine AUC values were approximately 1.7 fold (171.0 ng.hr/mL, range 96.1-255.3)<br />higher than those seen in a group of eighteen younger adults (101.4 ng.hr/mL, range 36.1-<br />182.9) from another study. Elderly male subjects had the highest observed mean increase,<br />approximately 2.4 fold (198.3 ng.hr/mL, range 155.6-255.3 versus 83.2 ng.hr/mL, range 41.1-<br />142.5 for younger males) while levels in elderly females were increased to a much lesser<br />extent, approximately 1.2 fold (143.8 ng.hr/mL, range 96.1-196.3 versus 115.9 ng.hr/mL, range<br />36.1-182.9 for younger females).</p><p>In light of these findings, therapy with BENZAFLEX XRin the elderly should be initiated with<br />a 5 mg dose and titrated slowly upward.</p><p><strong>Hepatic Impairment</strong><br />In a pharmacokinetic study of sixteen subjects with hepatic impairment (15 mild, 1 moderate<br />per Child-Pugh score), both AUC and Cmax were approximately double the values seen in the<br />healthy control group. Based on the findings, BENZAFLEX XRshould be used with caution in<br />subjects with mild hepatic impairment starting with the 5 mg dose and titrating slowly upward.<br />Due to the lack of data in subjects with more severe hepatic insufficiency, the use of<br />BENZAFLEX XRin subjects with moderate to severe impairment is not recommended.<br />No significant effect on plasma levels or bioavailability of BENZAFLEX XRor aspirin was<br />noted when single or multiple doses of the two drugs were administered concomitantly.<br />Concomitant administration of BENZAFLEX XRand naproxen or diflunisal was well tolerated<br />with no reported unexpected adverse effects. However combination therapy of BENZAFLEX<br />XRwith naproxen was associated with more side effects than therapy with naproxen alone,<br />primarily in the form of drowsiness. No well-controlled studies have been performed to<br />indicate that BENZAFLEX XRenhances the clinical effect of aspirin or other analgesics, or<br />whether analgesics enhance the clinical effect of BENZAFLEX XRin acute musculoskeletal<br />conditions.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Carcinogenesis, Mutagenesis, Impairment of Fertility</u><br />Long-term studies were conducted in CD-1 mice and Sprague-Dawley rats with<br />cyclobenzaprine to evaluate its carcinogenic potential. In an 81-week carcinogenicity study,<br />metastatic hemangiosarcoma was seen in 3 of 21 male mice at 10 mg/kg/day (2 times the<br />MRHD on a mg/m2 basis). In a 105-week carcinogenicity study, malignant astrocytoma was<br />seen in 3 of 50 male rats at 10 mg/kg/day (3 times the MRHD on a mg/m2 basis). There were<br />no tumor findings in female mice or rats.<br />Cyclobenzaprine HCl was not mutagenic or clastogenic in the following assays: an in vitro<br />Ames bacterial mutation assay, in vitro Chinese hamster ovary (CHO) cell chromosomal<br />aberration test, and in vivo mouse bone marrow micronucleus assay.<br />Cyclobenzaprine HCl had no effects on fertility and reproductive performance in male or<br />female rats at oral doses up to 20 mg/kg/day (6 times the MRHD on a mg/m2 basis).</p><p><u>Animal Toxicology and/or Pharmacology</u><br />In a 67-week study with rats that received cyclobenzaprine at oral doses of 10, 20 or 40<br />mg/kg/day (3 to 15 times the MRHD on mg/m2 basis), there were findings in the liver<br />consisting of midzonal vacuolation with lipidosis for males and midzonal and centrilobular<br />hepatocytic enlargement for females. In addition, there were findings of centrilobular<br />coagulative necrosis. In the higher dose groups, these microscopic changes were seen after 26<br />weeks and even earlier in rats that died prior to<br />26 weeks; at lower doses, these changes were not seen until after 26 weeks.</p><p>In a 26-week study with Cynomolgus monkeys that received cyclobenzaprine at oral of doses<br />of 2.5, 5, 10, or 20 mg/kg/day, one monkey at 20 mg/kg/day (15 times the MRHD on mg/m2<br />basis) was euthanized in week 17. Morbidity for this animal was attributed to findings of<br />chronic pancreatitis, cholecystitis, cholangitis, and focal liver necrosis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hypromellose,<br />Isopropyl alcohol,<br />Methylene chloride,<br />Colloidal silicon dioxide,<br />Ethyl cellulose, &amp;<br />Sugar spheres.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>This medicinal product does not require any special storage conditions.<br />Do not store above 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>PVC/PE/PVDC Clear.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special disposal.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                SPIMACO
AlQassim pharmaceutical plant
Saudi Pharmaceutical Industries &
Medical Appliance Corporation.
Saudi Arabia

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                May 2017.
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>